Retour
55
75
Également cotée sous
WXXWY
OTC
Fourchette du Jour
4,60 €
5,26 €
Fourchette 52 Semaines
2,26 €
5,61 €
Volume
32 250
Moyenne 50J / 200J
4,71 €
/
4,34 €
Clôture Précédente
4,60 €
Quick Summary
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (627 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 5,7 | 0,3 |
| P/B | 0,5 | 3,0 |
| ROE % | 8,2 | 3,7 |
| Net Margin % | 18,0 | 3,8 |
| Rev Growth 5Y % | 35,1 | 10,0 |
| D/E | 0,1 | 0,2 |
Objectif de Cours des Analystes
Aucune couverture d'analyste disponible
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2029 |
0,00 €
0,00 € – 0,00 €
|
38,61B | 0 |
| FY2028 |
2,04 €
1,93 € – 2,22 €
|
35,93B | 1 |
| FY2027 |
1,55 €
1,46 € – 1,69 €
|
30,30B | 1 |
No quarterly estimates available
Dividend History
Yield
0,00%
Payout Ratio
N/A
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Points Clés
Revenue grew 35,06% annually over 5 years — strong growth
Net margin of 17,97% shows strong profitability
Debt/Equity of 0,12 — conservative balance sheet
Generating 1,29B in free cash flow
P/E of 5,66 — trading at a low valuation
Revenue growth is decelerating — 1Y growth trails 5Y average by 25,43%
Croissance
Revenue Growth (5Y)
35,06%
Revenue (1Y)9,63%
Earnings (1Y)-1,28%
FCF Growth (3Y)N/A
Qualité
Return on Equity
8,17%
ROIC7,98%
Net Margin17,97%
Op. Margin26,63%
Sécurité
Debt / Equity
0,12
Current Ratio2,73
Interest Coverage31,56
Valorisation
P/E Ratio
5,66
Forward P/EN/A
P/B Ratio0,45
EV/EBITDA3,15
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 9,63% | Revenue Growth (3Y) | 10,59% |
| Earnings Growth (1Y) | -1,28% | Earnings Growth (3Y) | -12,87% |
| Revenue Growth (5Y) | 35,06% | Earnings Growth (5Y) | 18,73% |
| Profitability | |||
| Revenue (TTM) | 18,68B | Net Income (TTM) | 3,36B |
| ROE | 8,17% | ROA | 5,89% |
| Gross Margin | 40,97% | Operating Margin | 26,63% |
| Net Margin | 17,97% | Free Cash Flow (TTM) | 1,29B |
| ROIC | 7,98% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,12 | Current Ratio | 2,73 |
| Interest Coverage | 31,56 | ||
| Dividends | |||
| Dividend Yield | 0,00% | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | 5,66 | Forward P/E | N/A |
| P/B Ratio | 0,45 | P/S Ratio | 1,02 |
| PEG Ratio | 15,60 | Forward PEG | N/A |
| EV/EBITDA | 3,15 | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | 6,78% | ||
| Market Cap | 18,99B | Enterprise Value | 15,65B |
Income Statement
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 18,68B | 17,03B | 15,27B | 10,29B | 5,61B |
| Net Income | 3,36B | 3,40B | 4,42B | 3,39B | 1,69B |
| EPS (Diluted) | 0,78 | 0,77 | 1,01 | 0,77 | 0,40 |
| Gross Profit | 7,65B | 6,83B | 6,72B | 4,83B | 2,53B |
| Operating Income | 4,97B | 4,45B | 4,34B | 3,19B | 1,50B |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 56,98B | 56,58B | 49,56B | 44,03B | 28,96B |
| Total Liabilities | 11,50B | 12,56B | 13,35B | 11,33B | 8,06B |
| Shareholders' Equity | 41,82B | 40,33B | 35,05B | 32,28B | 20,56B |
| Total Debt | 4,94B | 4,56B | 4,42B | 4,30B | 3,33B |
| Cash & Equivalents | 8,28B | 9,67B | 6,40B | 9,00B | 7,10B |
| Current Assets | 23,57B | 21,20B | 18,47B | 19,53B | 14,20B |
| Current Liabilities | 8,62B | 7,64B | 9,32B | 8,26B | 4,50B |
Scores de Stratégies
This stock passed the criteria for 2 strategies
Score = fit strength (0–100)
Rank = position among all matches
#219 of 827
#14 of 709
Activité Récente
Entré
Deep Value Investing (Seth Klarman)
Mar 24, 2026
Entré
Defensive Investing (Benjamin Graham)
Mar 24, 2026